Synthetic Viral Controls - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510247467

Publication Date:

October 3, 2024

Pages:

121

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

Controls based on viral nucleic acids extracted from either an infected patient or from live virus propagated in cell culture have safety and security concerns.
The global market for Synthetic Viral Controls was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Synthetic Viral Controls was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Synthetic Viral Controls was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Synthetic Viral Controls was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Synthetic Viral Controls include Twist Bioscience, Vector Biolabs, Premade Lentivirus Particles, Telesis Bio, Thermo Fisher Scientific, Sigma Aldrich, Antibody Engineering, Amyris and Precigen, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Synthetic Viral Controls, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Synthetic Viral Controls by region & country, by Type, and by Application.
The Synthetic Viral Controls market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Viral Controls.
Market Segmentation
By Company
Twist Bioscience
Vector Biolabs
Premade Lentivirus Particles
Telesis Bio
Thermo Fisher Scientific
Sigma Aldrich
Antibody Engineering
Amyris
Precigen
Ginkgo Bioworks
Codexis
Impossible Foods
National Resilience
ElevateBio
Insitro
Apeel Sciences
Segment by Type:
Monkeypox Controls
SARS-COV-2 CONTROLS
Respiratory Virus Controls
Segment by Application
Child
Teenager
Youth
Middle-Aged
Elder
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Synthetic Viral Controls manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Synthetic Viral Controls in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Synthetic Viral Controls in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Synthetic Viral Controls Product Introduction
1.2 Global Synthetic Viral Controls Market Size Forecast
1.3 Synthetic Viral Controls Market Trends & Drivers
1.3.1 Synthetic Viral Controls Industry Trends
1.3.2 Synthetic Viral Controls Market Drivers & Opportunity
1.3.3 Synthetic Viral Controls Market Challenges
1.3.4 Synthetic Viral Controls Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Synthetic Viral Controls Players Revenue Ranking (2023)
2.2 Global Synthetic Viral Controls Revenue by Company (2019-2024)
2.3 Key Companies Synthetic Viral Controls Manufacturing Base Distribution and Headquarters
2.4 Key Companies Synthetic Viral Controls Product Offered
2.5 Key Companies Time to Begin Mass Production of Synthetic Viral Controls
2.6 Synthetic Viral Controls Market Competitive Analysis
2.6.1 Synthetic Viral Controls Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Synthetic Viral Controls Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Viral Controls as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monkeypox Controls
3.1.2 SARS-COV-2 CONTROLS
3.1.3 Respiratory Virus Controls
3.2 Global Synthetic Viral Controls Sales Value by Type
3.2.1 Global Synthetic Viral Controls Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Synthetic Viral Controls Sales Value, by Type (2019-2030)
3.2.3 Global Synthetic Viral Controls Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Child
4.1.2 Teenager
4.1.3 Youth
4.1.4 Middle-Aged
4.1.5 Elder
4.1.6 Others
4.2 Global Synthetic Viral Controls Sales Value by Application
4.2.1 Global Synthetic Viral Controls Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Synthetic Viral Controls Sales Value, by Application (2019-2030)
4.2.3 Global Synthetic Viral Controls Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Synthetic Viral Controls Sales Value by Region
5.1.1 Global Synthetic Viral Controls Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Synthetic Viral Controls Sales Value by Region (2019-2024)
5.1.3 Global Synthetic Viral Controls Sales Value by Region (2025-2030)
5.1.4 Global Synthetic Viral Controls Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Synthetic Viral Controls Sales Value, 2019-2030
5.2.2 North America Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Synthetic Viral Controls Sales Value, 2019-2030
5.3.2 Europe Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Synthetic Viral Controls Sales Value, 2019-2030
5.4.2 Asia Pacific Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Synthetic Viral Controls Sales Value, 2019-2030
5.5.2 South America Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Synthetic Viral Controls Sales Value, 2019-2030
5.6.2 Middle East & Africa Synthetic Viral Controls Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Synthetic Viral Controls Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Synthetic Viral Controls Sales Value
6.3 United States
6.3.1 United States Synthetic Viral Controls Sales Value, 2019-2030
6.3.2 United States Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Synthetic Viral Controls Sales Value, 2019-2030
6.4.2 Europe Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Synthetic Viral Controls Sales Value, 2019-2030
6.5.2 China Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.5.3 China Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Synthetic Viral Controls Sales Value, 2019-2030
6.6.2 Japan Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Synthetic Viral Controls Sales Value, 2019-2030
6.7.2 South Korea Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Synthetic Viral Controls Sales Value, 2019-2030
6.8.2 Southeast Asia Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Synthetic Viral Controls Sales Value, 2019-2030
6.9.2 India Synthetic Viral Controls Sales Value by Type (%), 2023 VS 2030
6.9.3 India Synthetic Viral Controls Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Twist Bioscience
7.1.1 Twist Bioscience Profile
7.1.2 Twist Bioscience Main Business
7.1.3 Twist Bioscience Synthetic Viral Controls Products, Services and Solutions
7.1.4 Twist Bioscience Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.1.5 Twist Bioscience Recent Developments
7.2 Vector Biolabs
7.2.1 Vector Biolabs Profile
7.2.2 Vector Biolabs Main Business
7.2.3 Vector Biolabs Synthetic Viral Controls Products, Services and Solutions
7.2.4 Vector Biolabs Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.2.5 Vector Biolabs Recent Developments
7.3 Premade Lentivirus Particles
7.3.1 Premade Lentivirus Particles Profile
7.3.2 Premade Lentivirus Particles Main Business
7.3.3 Premade Lentivirus Particles Synthetic Viral Controls Products, Services and Solutions
7.3.4 Premade Lentivirus Particles Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.3.5 Telesis Bio Recent Developments
7.4 Telesis Bio
7.4.1 Telesis Bio Profile
7.4.2 Telesis Bio Main Business
7.4.3 Telesis Bio Synthetic Viral Controls Products, Services and Solutions
7.4.4 Telesis Bio Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.4.5 Telesis Bio Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Synthetic Viral Controls Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 Sigma Aldrich
7.6.1 Sigma Aldrich Profile
7.6.2 Sigma Aldrich Main Business
7.6.3 Sigma Aldrich Synthetic Viral Controls Products, Services and Solutions
7.6.4 Sigma Aldrich Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.6.5 Sigma Aldrich Recent Developments
7.7 Antibody Engineering
7.7.1 Antibody Engineering Profile
7.7.2 Antibody Engineering Main Business
7.7.3 Antibody Engineering Synthetic Viral Controls Products, Services and Solutions
7.7.4 Antibody Engineering Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.7.5 Antibody Engineering Recent Developments
7.8 Amyris
7.8.1 Amyris Profile
7.8.2 Amyris Main Business
7.8.3 Amyris Synthetic Viral Controls Products, Services and Solutions
7.8.4 Amyris Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.8.5 Amyris Recent Developments
7.9 Precigen
7.9.1 Precigen Profile
7.9.2 Precigen Main Business
7.9.3 Precigen Synthetic Viral Controls Products, Services and Solutions
7.9.4 Precigen Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.9.5 Precigen Recent Developments
7.10 Ginkgo Bioworks
7.10.1 Ginkgo Bioworks Profile
7.10.2 Ginkgo Bioworks Main Business
7.10.3 Ginkgo Bioworks Synthetic Viral Controls Products, Services and Solutions
7.10.4 Ginkgo Bioworks Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.10.5 Ginkgo Bioworks Recent Developments
7.11 Codexis
7.11.1 Codexis Profile
7.11.2 Codexis Main Business
7.11.3 Codexis Synthetic Viral Controls Products, Services and Solutions
7.11.4 Codexis Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.11.5 Codexis Recent Developments
7.12 Impossible Foods
7.12.1 Impossible Foods Profile
7.12.2 Impossible Foods Main Business
7.12.3 Impossible Foods Synthetic Viral Controls Products, Services and Solutions
7.12.4 Impossible Foods Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.12.5 Impossible Foods Recent Developments
7.13 National Resilience
7.13.1 National Resilience Profile
7.13.2 National Resilience Main Business
7.13.3 National Resilience Synthetic Viral Controls Products, Services and Solutions
7.13.4 National Resilience Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.13.5 National Resilience Recent Developments
7.14 ElevateBio
7.14.1 ElevateBio Profile
7.14.2 ElevateBio Main Business
7.14.3 ElevateBio Synthetic Viral Controls Products, Services and Solutions
7.14.4 ElevateBio Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.14.5 ElevateBio Recent Developments
7.15 Insitro
7.15.1 Insitro Profile
7.15.2 Insitro Main Business
7.15.3 Insitro Synthetic Viral Controls Products, Services and Solutions
7.15.4 Insitro Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.15.5 Insitro Recent Developments
7.16 Apeel Sciences
7.16.1 Apeel Sciences Profile
7.16.2 Apeel Sciences Main Business
7.16.3 Apeel Sciences Synthetic Viral Controls Products, Services and Solutions
7.16.4 Apeel Sciences Synthetic Viral Controls Revenue (US$ Million) & (2019-2024)
7.16.5 Apeel Sciences Recent Developments
8 Industry Chain Analysis
8.1 Synthetic Viral Controls Industrial Chain
8.2 Synthetic Viral Controls Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Synthetic Viral Controls Sales Model
8.5.2 Sales Channel
8.5.3 Synthetic Viral Controls Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Twist Bioscience
Vector Biolabs
Premade Lentivirus Particles
Telesis Bio
Thermo Fisher Scientific
Sigma Aldrich
Antibody Engineering
Amyris
Precigen
Ginkgo Bioworks
Codexis
Impossible Foods
National Resilience
ElevateBio
Insitro
Apeel Sciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂